PMID: 15218400Jun 26, 2004Paper

Genetic determinants of low high-density lipoprotein cholesterol

Current Opinion in Cardiology
Michael Miller, Min Zhan

Abstract

High-density lipoprotein cholesterol (HDL-C) has been well established as an inverse predictor of coronary heart disease (CHD), and in recent years, investigations have focused on the genetic regulation of high-density lipoprotein. Although numerous candidate genes contribute to the low HDL-C phenotype, their impact on CHD is heterogeneous, reflecting diverse gene-gene interactions and gene-environmental relationships. This review summarizes recent data involving HDL regulatory genes and their role in atherothrombosis. The primary genetic determinants associated with relative HDL-C deficiency states are the ATP binding cassette protein, ABCA1; apolipoprotein (APO) A1; and lecithin cholesteryl acyl transferase. Other potentially important candidates invoked in low HDL-C syndromes in humans include APOC3, lipoprotein lipase, sphingomyelin phosphodiesterase 1, and glucocerebrosidase. Molecular variation in ABCAI and APOAI and, in selected cases, lecithin cholesteryl acyl transferase deficiency have been associated with increased CHD, whereas two notable variants, APOAIMilano and APOAIParis, are associated with reduced risk. Low HDL-C syndromes have generally been correlated with an increased risk of CHD. However, single-gene abnor...Continue Reading

Associated Clinical Trials

References

Jan 1, 1978·Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum·J FrohlichK A Evelyn
Jan 1, 1992·Annual Review of Cell Biology·C F Higgins
Apr 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·T MatsunagaH Hamaguchi
Oct 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·S K KarathanasisI A Haddad
May 1, 1988·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·R D AbbottW P Castelli
Feb 16, 1972·Biochemical and Biophysical Research Communications·B I Brown, D H Brown
Jan 31, 1972·Biochemical and Biophysical Research Communications·W V Brown, M L Baginsky
Sep 1, 1995·Arteriosclerosis, Thrombosis, and Vascular Biology·M Tilly-KiesiM R Taskinen
May 1, 1994·Atherosclerosis·C Serfaty-LacrosniereR S Lees
Apr 22, 1993·The New England Journal of Medicine·D A HellerG E McClearn
Dec 13, 1996·The Journal of Biological Chemistry·B L DreesH C Nelson
Jun 1, 1997·Current Opinion in Lipidology·A RigottiM Krieger
Feb 12, 1999·Arteriosclerosis, Thrombosis, and Vascular Biology·D LiJ L Mehta
May 14, 1999·Arteriosclerosis, Thrombosis, and Vascular Biology·G FranceschiniF Bernini
Oct 30, 1999·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·U DaumA von Eckardstein
Jan 12, 2001·The American Journal of Cardiology·M MillerK Zeller
Feb 13, 2001·Biochemical and Biophysical Research Communications·A T RemaleyH B Brewer
May 23, 2001·JAMA : the Journal of the American Medical Association·UNKNOWN Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
Nov 2, 2001·Atherosclerosis·E J SchaeferP J Jones
Nov 28, 2002·Journal of Lipid Research·Martin MerkelIra J Goldberg

❮ Previous
Next ❯

Citations

May 18, 2006·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·C M BrownC F Sing
Aug 19, 2008·Current Atherosclerosis Reports·Iulia IatanJacques Genest
Apr 28, 2010·Journal of Lipid Research·Daphna Weissglas-Volkov, Päivi Pajukanta
Oct 11, 2007·Pharmacogenomics·George V Z Dedoussis
Dec 3, 2010·Journal of Clinical Lipidology·Leila ChaychiErnest J Schaefer
Dec 1, 2009·Journal of Clinical Lipidology·Zuhier AwanJacques Genest
May 12, 2009·Metabolism: Clinical and Experimental·Wanee PlengpanichWeerapan Khovidhunkit
Mar 27, 2007·Translational Research : the Journal of Laboratory and Clinical Medicine·Myrna MantaringMichael Miller
Oct 21, 2006·International Journal of Cardiology·Michael MillerStephen Havas
Jan 18, 2008·Clinical Genetics·T L SlatterS P A McCormick
Jun 1, 2006·Current Opinion in Colloid & Interface Science·J Bruce GermanAngela M Zivkovic
Aug 15, 2014·Critical Reviews in Clinical Laboratory Sciences·Dinushan Nesan, Dominic S Ng
Jan 3, 2006·Journal of Lipid Research·Bradley E AouizeratClive R Pullinger
Apr 11, 2013·International Journal of Molecular Sciences·Roberto Martínez-BeamonteJesús Osada
Apr 3, 2008·The Journal of Biological Chemistry·Christian WolfrumMarkus Stoffel
May 25, 2007·Cancer Research·Unhee LimDemetrius Albanes

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.